Lantheus Holdings, Inc. (LNTH)
USD 89.5
(-1.56%)
USD 89.5
(-1.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.65 Billion USD | 24.97% |
| 2022 | 1.32 Billion USD | 52.96% |
| 2021 | 863.78 Million USD | -0.69% |
| 2020 | 869.82 Million USD | 114.28% |
| 2019 | 405.91 Million USD | -7.71% |
| 2018 | 439.83 Million USD | 14.58% |
| 2017 | 383.85 Million USD | 50.0% |
| 2016 | 255.89 Million USD | 5.58% |
| 2015 | 242.37 Million USD | -2.88% |
| 2014 | 249.57 Million USD | -4.49% |
| 2013 | 261.31 Million USD | -19.51% |
| 2012 | 324.65 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.83 Billion USD | 10.91% |
| 2024 Q2 | 1.93 Billion USD | 5.92% |
| 2023 FY | 1.65 Billion USD | 24.97% |
| 2023 Q3 | 1.52 Billion USD | 13.75% |
| 2023 Q4 | 1.65 Billion USD | 8.51% |
| 2023 Q1 | 1.34 Billion USD | 2.12% |
| 2023 Q2 | 1.33 Billion USD | -0.86% |
| 2022 Q4 | 1.32 Billion USD | 20.56% |
| 2022 Q2 | 1.01 Billion USD | 8.64% |
| 2022 Q1 | 933.16 Million USD | 8.03% |
| 2022 FY | 1.32 Billion USD | 52.96% |
| 2022 Q3 | 1.09 Billion USD | 8.1% |
| 2021 FY | 863.78 Million USD | -0.69% |
| 2021 Q1 | 843.44 Million USD | -3.03% |
| 2021 Q2 | 857.8 Million USD | 1.7% |
| 2021 Q3 | 847.81 Million USD | -1.16% |
| 2021 Q4 | 863.78 Million USD | 1.88% |
| 2020 FY | 869.82 Million USD | 114.28% |
| 2020 Q1 | 404.12 Million USD | -0.44% |
| 2020 Q3 | 879.59 Million USD | -0.01% |
| 2020 Q4 | 869.82 Million USD | -1.11% |
| 2020 Q2 | 879.69 Million USD | 117.68% |
| 2019 Q2 | 390.25 Million USD | -12.09% |
| 2019 Q4 | 405.91 Million USD | 0.87% |
| 2019 FY | 405.91 Million USD | -7.71% |
| 2019 Q1 | 443.9 Million USD | 0.93% |
| 2019 Q3 | 402.4 Million USD | 3.12% |
| 2018 Q4 | 439.83 Million USD | 3.53% |
| 2018 Q1 | 392.58 Million USD | 2.27% |
| 2018 FY | 439.83 Million USD | 14.58% |
| 2018 Q2 | 401.8 Million USD | 2.35% |
| 2018 Q3 | 424.81 Million USD | 5.73% |
| 2017 Q4 | 383.85 Million USD | 36.59% |
| 2017 FY | 383.85 Million USD | 50.0% |
| 2017 Q3 | 281.02 Million USD | 4.91% |
| 2017 Q2 | 267.87 Million USD | 7.34% |
| 2017 Q1 | 249.56 Million USD | -2.48% |
| 2016 Q4 | 255.89 Million USD | 0.36% |
| 2016 FY | 255.89 Million USD | 5.58% |
| 2016 Q1 | 249.26 Million USD | 2.84% |
| 2016 Q2 | 259.26 Million USD | 4.01% |
| 2016 Q3 | 254.96 Million USD | -1.66% |
| 2015 Q3 | 236.13 Million USD | 1.11% |
| 2015 Q4 | 242.37 Million USD | 2.65% |
| 2015 Q2 | 233.55 Million USD | -6.83% |
| 2015 Q1 | 250.65 Million USD | 0.44% |
| 2015 FY | 242.37 Million USD | -2.88% |
| 2014 Q4 | 249.57 Million USD | -4.0% |
| 2014 FY | 249.57 Million USD | -4.49% |
| 2014 Q1 | 260.96 Million USD | -0.13% |
| 2014 Q2 | 255.23 Million USD | -2.19% |
| 2014 Q3 | 259.97 Million USD | 1.86% |
| 2013 FY | 261.31 Million USD | -19.51% |
| 2013 Q1 | 312.83 Million USD | -3.64% |
| 2013 Q3 | 283.02 Million USD | -4.22% |
| 2013 Q2 | 295.5 Million USD | -5.54% |
| 2013 Q4 | 261.31 Million USD | -7.67% |
| 2012 Q4 | 324.65 Million USD | 0.0% |
| 2012 FY | 324.65 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -2390.587% |
| Safety Shot Inc | 12.7 Million USD | -12891.782% |
| Bright Green Corporation | 17.4 Million USD | -9387.701% |
| Embecta Corp. | 1.21 Billion USD | -35.964% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -82.564% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -2775.664% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -44.419% |
| Dynavax Technologies Corporation | 997.09 Million USD | -65.596% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -702.323% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -126.714% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | -4.876% |
| PainReform Ltd. | 9.93 Million USD | -16527.885% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -5937.779% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -5937.779% |
| SCYNEXIS, Inc. | 128.41 Million USD | -1185.821% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -7039.469% |
| Journey Medical Corporation | 76.84 Million USD | -2048.563% |
| Alpha Teknova, Inc. | 128.58 Million USD | -1184.071% |
| Procaps Group, S.A. | 460.18 Million USD | -258.8% |
| Theratechnologies Inc. | 77.76 Million USD | -2023.145% |
| Harrow Health, Inc. | 311.75 Million USD | -429.63% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -10986.745% |
| Biofrontera Inc. | 27.93 Million USD | -5811.317% |
| DURECT Corporation | 45.18 Million USD | -3553.874% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -17.188% |
| Cronos Group Inc. | 1.13 Billion USD | -45.572% |
| OptiNose, Inc. | 107.72 Million USD | -1432.688% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -250.508% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -2851.168% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -7064.226% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -258.926% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -13754.04% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1919.11% |
| Radius Health, Inc. | 1.71 Billion USD | 3.776% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -2998.594% |
| ProPhase Labs, Inc. | 91.92 Million USD | -1696.152% |
| Phibro Animal Health Corporation | 982.18 Million USD | -68.11% |
| Procaps Group S.A. | 460.18 Million USD | -258.8% |
| Alvotech | 950.09 Million USD | -73.789% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -3712.485% |
| Viatris Inc. | 47.68 Billion USD | 96.537% |
| Rockwell Medical, Inc. | 52.17 Million USD | -3064.758% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -1298.153% |
| SIGA Technologies, Inc. | 254.83 Million USD | -547.926% |
| Tilray Brands, Inc. | 4.33 Billion USD | 61.914% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -503.265% |
| Shineco, Inc. | 84.17 Million USD | -1861.465% |
| PetIQ, Inc. | 868.22 Million USD | -90.175% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -19467.524% |
| Incannex Healthcare Limited | 17.04 Million USD | -9585.863% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 49.217% |
| Alimera Sciences, Inc. | 153.52 Million USD | -975.499% |
| Silver Spike Investment Corp. | 88.57 Million USD | -1764.099% |
| Assertio Holdings, Inc. | 286.41 Million USD | -476.48% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -27642.309% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -4785.664% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -5184.861% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -12363.818% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -532.319% |
| Hempacco Co., Inc. | 18.04 Million USD | -9051.148% |
| Talphera, Inc. | 20.39 Million USD | -7995.852% |
| Alvotech | 950.09 Million USD | -73.789% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -306.527% |
| Currenc Group, Inc. | 141.49 Million USD | -1066.969% |
| Kamada Ltd. | 351.96 Million USD | -369.117% |
| Indivior PLC | 1.95 Billion USD | 15.38% |
| Evoke Pharma, Inc. | 7.06 Million USD | -23259.104% |
| Flora Growth Corp. | 23.62 Million USD | -6888.695% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -12363.818% |
| Evolus, Inc. | 188.99 Million USD | -773.633% |
| HUTCHMED (China) Limited | 1.27 Billion USD | -29.019% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | -9.137% |
| Akanda Corp. | 8.83 Million USD | -18578.171% |